论文部分内容阅读
目的:研究米索前列醇对产后宫缩乏力性出血的预防及治疗效果。方法:随机将400例产妇分为两组,对照组200例,使用缩宫素预防产后出血;实验组200例,使用米索前列醇预防产后出血,分析比较两组的疗效。结果:实验组使用米索前列醇,相较对照组使用缩宫素对产妇的血压、脉搏影响小,第三产程时间短,产后2h、24h的出血量少(P<0.05),各组的不良反应发生率没有显著性差异(P>0.05)。结论:相较于缩宫素,米索前列醇防治产后出血效果良好,值得临床进一步推广。
Objective: To study the prevention and treatment effect of misoprostol on postpartum uterine inert bleeding. Methods: 400 maternal women were randomly divided into two groups, the control group of 200 cases, the use of oxytocin to prevent postpartum hemorrhage; experimental group of 200 cases, the use of misoprostol to prevent postpartum hemorrhage, analysis of the efficacy of the two groups. Results: Compared with the control group, the use of oxytocin had no significant effect on blood pressure and pulse in the third trimester, shortened the third stage of labor and less bleeding at 2h and 24h after delivery (P <0.05) There was no significant difference in the incidence of adverse reactions (P> 0.05). Conclusion: Compared with oxytocin, misoprostol is effective in preventing and treating postpartum hemorrhage, and it is worth further clinical promotion.